Mark Goldsmith

Revolution Medicines’ Promising Pancreatic Cancer Drug Achieves Success in Late-Stage Trials: A Game Changer in Treatment?

Pancreatic cancer is a serious illness with a very low survival rate of just 13% over five years. However, recent ... Read more